d-Dimer elevation and adverse outcomes
Open Access
- 9 July 2014
- journal article
- review article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 39 (1) , 55-59
Abstract
D-Dimer is a biomarker of fibrin formation and degradation. While a d-dimer within normal limits is used to rule out the diagnosis of deep venous thrombosis and pulmonary embolism among patients with a low clinical probability of venous thromboembolism (VTE), the prognostic association of an elevated d-dimer with adverse outcomes has received far less emphasis. An elevated d-dimer is independently associated with an increased risk for incident VTE, recurrent VTE, and mortality. An elevated d-dimer is an independent correlate of increased mortality and subsequent VTE across a broad variety of disease states. Therefore, medically ill subjects in whom the d-dimer is elevated constitute a high risk subgroup in which the prospective evaluation of the efficacy and safety of antithrombotic therapy is warranted.Keywords
This publication has 52 references indexed in Scilit:
- Value of D-dimer and C reactive protein in predicting inhospital death in acute aortic dissectionHeart, 2013
- Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI studyHaematologica, 2013
- Novel High-Sensitive D-Dimer Determination Predicts Chemotherapy-Associated Venous Thromboembolism in Intermediate Risk Lung Cancer PatientsClinical Lung Cancer, 2012
- d-dimer is a significant prognostic factor in patients with suspected infection and sepsisThe American Journal of Emergency Medicine, 2012
- High D-dimer levels are associated with poor prognosis in cancer patientsHaematologica, 2012
- Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohortsBMJ, 2010
- Cancer, Clots and Consensus: New Understanding of an Old ProblemJournal of Clinical Oncology, 2009
- D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis StudyJournal of Clinical Oncology, 2009
- Plasma d-Dimer Levels Correlate With Outcomes in Patients With Community-Acquired PneumoniaChest, 2004
- Hemostatic Markers in Acute Ischemic StrokeStroke, 1996